Ken Griffin's position in Novo Nordisk - ADR is currently worth $61.8 Million. That's 0.07% of their equity portfolio (347th largest holding). The first Novo Nordisk - ADR trade was made in Q3 2014. Since then Ken Griffin bought shares 45 more times and sold shares on 40 occasions. The stake costed the investor $29.2 Million, netting the investor a gain of 112% so far.